Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
164
Frequently Asked Questions
What is Market Cap of Rigel Pharmaceuticals?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rigel Pharmaceuticals market cap is $741.53M.
What is the 52-week high for Rigel Pharmaceuticals?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rigel Pharmaceuticals 52 week high is $43.72 as of September 08, 2025.
What is the 52-week low for Rigel Pharmaceuticals?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rigel Pharmaceuticals 52 week low is $12.66 as of September 08, 2025.
What is Rigel Pharmaceuticals stock price today?
Rigel Pharmaceuticals stock price today is $40.87.
What was Rigel Pharmaceuticals stock price yesterday?
Rigel Pharmaceuticals stock price yesterday was $41.34.
What is the PE ratio of Rigel Pharmaceuticals?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rigel Pharmaceuticals’s P/E ratio is 7.64.
What is the Price-to-Book ratio of Rigel Pharmaceuticals?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rigel Pharmaceuticals P/B ratio is 9.0502.
What is the 50-day moving average of Rigel Pharmaceuticals?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rigel Pharmaceuticals 50-day moving average is $27.86.
How many employess does Rigel Pharmaceuticals has?
